The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2024

Save the date for the CDDF Multi-Stakeholder workshops in 2024!

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

[Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Clinical Research in Central and Eastern Europe]

The Cancer Drug Development Forum (CDDF) is excited to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe. Held in Krakow, Poland on 15-16 April 2024, the...

🔔 📣 NEW PUBLICATION: Executive Summary: CDDF Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe (15-16 April 2024, PL)

The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of its recent workshop on Clinical Research in Central and Eastern Europe has been published today and is available to all our stakeholders.  This workshop took place on 15-...

Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community

🎉 📣 [Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community] The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, Arvinas, who will make collaborative efforts with the CDDF to improve cancer drug development. Arvinas is...

NEW PUBLICATION-INTERVIEW ARTICLE: Collaboration and Partnerships in Accelerating Cancer Drug Development

The Cancer Drug Development Forum (CDDF) is delighted to announce that Prof. Jaap Verweij and Prof. Ruth Plummer’s article, “Collaboration and Partnerships in Accelerating Cancer Drug Development” has been published in the April edition of Open Access Government. In...

Key Takeaways from the CDDF Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe (15 April 2024, Krakow)

The first day of the CDDF workshop on Clinical Research in Central and Eastern Europe brought together a diverse group of stakeholders to facilitate dialogue and collaboration. Here are the key takeaways from Day 1's program:   SESSION 1: CURRENT STATUS OF...

Gain Valuable Perspectives from Participants of the CDDF Annual Conference and Get an Inside Look at Its Multi-Stakeholder Discussions (Feb 2024)

View the CDDF’s interviews with participants at the CDDF Annual Conference 2024 (5 – 7 February 2024, Noordwijk) and gain valuable perspectives on key topics in oncology from diverse stakeholders. https://youtu.be/4LezZVWhgZM Continued dialogue and collaboration is...

[ 🔔 📣 NEW PUBLICATION: EXECUTIVE SUMMARY OF THE CDDF ANNUAL CONFERENCE 2024] The Cancer Drug Development Forum (CDDF) is delighted to announced that its executive summary of this year’s Annual Conference has been published today and is available to all our...

Key Takeaways from the CDDF Webinar on Clinical Research in Central and Eastern Europe

The Cancer Drug Development Forum (CDDF) held a live webinar on “Clinical Research in Central and Eastern Europe, Realising the opportunities “ on Monday 12 February 2024 at 17:00 (CET) / 11:00 (EST). In this webinar, Susan Bhatti (Merck BV, NL), Mark Lawler (Queen’s...

CDDF Annual Conference 2024 – Key Takeaways from Session 3: Decentralized Care and Trials

The second day of the CDDF Annual Conference 2024 brought multi-stakeholder speakers and audience together to facilitate candid dialogue on important topics in oncology. Here are the key takeaways from Session 3: Decentralized Care and Trials: 🔶 The Covid-19 pandemic...

CDDF Annual Conference 2024 – Key Takeaways from Session 1: Real World Evidence

The first day of the CDDF Annual Conference 2024 generated highly productive and vibrant dialogue around critical questions about real world evidence and underscoring the importance of collaborative efforts. Here are the key takeaways from Session 1: Real World...

CDDF Webinar: COVID-19 and Cancer – Time for a Reset to Repair the Damage Done (Jan 2024)

The recording of the recent CDDF webinar on COVID-19 and Cancer – Time for a Reset to Repair the Damage Done is available here. Enjoy the insightful talks from Mark Lawler (Queen’s University Belfast; CDDF Board Member, UK), Ajay Aggarwal (The London School of Hygiene and Tropical Medicine, UK) and Debbie Keatley (Cancer Research UK) followed by a Q&A session.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70